Company intelligence / Profile preview

Elisa Biotech

Wuhan, Hubei, China

Ownership: Private
Development stage: Other

Overview

Elisa Biotech is a life science company based in Wuhan, China, specializing in the development and manufacturing of high-quality biological reagents. The company primarily focuses on Enzyme-Linked Immunosorbent Assay (ELISA) kits, recombinant proteins, and antibodies for research use across various species including human, mouse, rat, and bovine. Their product portfolio supports research in areas such as immunology, oncology, and cell biology, providing tools for academic and industrial laboratories worldwide. Elisa Biotech is recognized for its extensive catalog of diagnostic and research kits that facilitate the detection of cytokines, hormones, and other biomarkers.

Modalities: AntibodyProteinRecombinant protein
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on Elisa Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Elisa Biotech.

Explore the full profile